Experience the trailer
Get a sneak peek at our first season.
Experience the trailer
Get a sneak peek at our first season.
Subscribe where you listen
Subscribe where you listen
Meet the people, plants & machines unlocking nature’s hidden chemistry.
Curiosity meets code. Plants meet processors. This is the frontier where ancient chemistry and modern intelligence converge to shape the future of therapeutics.
A mesmerizing journey into nature's secrets.
"
-
Meet the people, plants & machines unlocking nature’s hidden chemistry.
Curiosity meets code. Plants meet processors. This is the frontier where ancient chemistry and modern intelligence converge to shape the future of therapeutics.
A mesmerizing journey into nature's secrets.
"
-
The Nature of Discovery
A four-part origin story of how we lost nature's chemistry, and how Enveda is bringing it back.
The Nature of Discovery
A four-part origin story of how we lost nature's chemistry, and how Enveda is bringing it back.
About the host
Lab Notes
Daniel Wee, PhD is the Chief eXecution Officer at Enveda. Dan has been with the company since before the seed round, leading Finance, Legal, Quality, SynBio, and Special Projects. With over 10 years of experience in building products and leading companies, he bridges the science, business and operations to make sure Enveda is running as fast as we can reliably and safely. Dan earned his PhD in Molecular Biology and has several publications in high-impact journals. Prior to joining Enveda, Dan, founded and led as CEO a synthetic biology company focused on scalable and cost-effective biologics manufacturing for large pharmaceutical companies, which was later acquired by Vectron Biosolutions. Outside of work, Dan enjoys spending time with his family, cooking, playing music, skiing and random walks.
About the host
Daniel Wee, PhD is the Chief eXecution Officer at Enveda. Dan has been with the company since before the seed round, leading Finance, Legal, Quality, SynBio, and Special Projects. With over 10 years of experience in building products and leading companies, he bridges the science, business and operations to make sure Enveda is running as fast as we can reliably and safely. Dan earned his PhD in Molecular Biology and has several publications in high-impact journals. Prior to joining Enveda, Dan, founded and led as CEO a synthetic biology company focused on scalable and cost-effective biologics manufacturing for large pharmaceutical companies, which was later acquired by Vectron Biosolutions. Outside of work, Dan enjoys spending time with his family, cooking, playing music, skiing and random walks.
Subscribe where you listen
Subscribe where you listen
The future
is ancient
Enveda is writing a healthier, more hopeful future by
empowering scientists to access the unexplored potential
of life’s chemical code.
The future
is ancient
Enveda is writing a healthier, more hopeful future by empowering scientists to access the unexplored potential of life’s chemical code.
Powered by
Powered by
